生肝健脾湯加三七根이 흰쥐의 간섬유화 억제에 미치는 영향
Inhibitory Effect of Saengangeonbitang-gasamchilgn on Liver Fibrosis in Rat
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The aim of this study was to investigate the inhibitory effect of Saengangeonbitang-gasamchilgn(SGGBTGSCG) on collagen production in rat hepatic stellate cells(HSC) and on the TAA-induced chronic liver injury model in rats.Methods : 1) HSCs were treated with SGGBTGSCG extract powder(50% EtOH SGGBTGSCG, dw SGGBTGSCG). After the treatment, MTT assay, BrdU assay and procollagen assay were done. In addition, gene expressions of collagen type 1α2, ASMA, TIMP1, and TIMP2, all of which are known to be associated with liver fibrosis, were analyzed by RT-PCR. 2) Liver fibrosis was developed in rats by injection of TAA 3 times a week for 5 weeks. After the SGGBTGSCG-treatment, body weight, liver & spleen weight, liver function test, the complete blood cell count and the change of portal pressure were studied.Results : In MTT assay, SGGBTGSCG significantly decreased the viability of HSCs in a dose-dependent manner. In BrdU assay, SGGBTGSCG significantly inhibited the HSC proliferation in a dose-dependant manner. In procollagen assay, SGGBTGSCG decreased procollagen production by HSC. In the change of rats' liver and spleen weight, TAA+SGGBTGSCG groups showed little difference compared with TAA-only group.In the liver function test, SGGBTGSCG decreased the serum level of ALT, AST, and Alp elevated by TAA. In the complete blood cell count, SGGBTGSCG significantly decreased WBC elevated by TAA and increased RBC and Hct lowered by TAA.In the change of portal pressure, SGGBTGSCG decreased portal pressure elevated by TAA.Conclusions : These results suggest that SGGBTGSCG is beneficial in the treatment of cirrhotic patients as well as for patients with chronic hepatitis.
Abstract
The aim of this study was to investigate the inhibitory effect of Saengangeonbitang-gasamchilgn(SGGBTGSCG) on collagen production in rat hepatic stellate cells(HSC) and on the TAA-induced chronic liver injury model in rats.Methods : 1) HSCs were treated with SGGBTGSCG extract powder(50% EtOH SGGBTGSCG, dw SGGBTGSCG). After the treatment, MTT assay, BrdU assay and procollagen assay were done. In addition, gene expressions of collagen type 1α2, ASMA, TIMP1, and TIMP2, all of which are known to be associated with liver fibrosis, were analyzed by RT-PCR. 2) Liver fibrosis was developed in rats by injection of TAA 3 times a week for 5 weeks. After the SGGBTGSCG-treatment, body weight, liver & spleen weight, liver function test, the complete blood cell count and the change of portal pressure were studied.Results : In MTT assay, SGGBTGSCG significantly decreased the viability of HSCs in a dose-dependent manner. In BrdU assay, SGGBTGSCG significantly inhibited the HSC proliferation in a dose-dependant manner. In procollagen assay, SGGBTGSCG decreased procollagen production by HSC. In the change of rats' liver and spleen weight, TAA+SGGBTGSCG groups showed little difference compared with TAA-only group.In the liver function test, SGGBTGSCG decreased the serum level of ALT, AST, and Alp elevated by TAA. In the complete blood cell count, SGGBTGSCG significantly decreased WBC elevated by TAA and increased RBC and Hct lowered by TAA.In the change of portal pressure, SGGBTGSCG decreased portal pressure elevated by TAA.Conclusions : These results suggest that SGGBTGSCG is beneficial in the treatment of cirrhotic patients as well as for patients with chronic hepatitis.
참고문헌 (23)
- 통계청, "2006년 사망원인 통계연보" (2007)
- 전국한의과대학 간계내과학 교수, "肝系內科學", pp.323~325 (2001), 동양의학연구원
- 김병운, "만성 간염 3,136례에 대한 임상분석과 生肝健脾湯의 치료효과", 대한한의학회지, 14(1), pp.218~215 (1993)
- 김영철, "茵蔯淸肝湯의 안전성에 관한 연구", 경희한의대논문집, 20(1), pp.57~89 (1997)
- 전국 한의과대학 본초학교수, "본초학" (1991), 영림사
- 안정희, "랫드 간경변 모델에서 발현되는 단백질의 탐색", 대한간학회지, 12(1), pp.93~102 (2006), 대한간학회
- 박형구, "茵蔯五苓散이 급성 alcohol, 고지혈증 및 Galactosamine 중독 백서의 간손상에 미치는 영향", 대한한의학회지, 14(2), pp.254~269 (1993)
- 김진주, "茵蔯淸肝湯이 MHV-2로 유발된 마우스의 손상간에 미치는 영향" (1996), 경희대학교 대학원
- 김성아, 우홍정, 김영철, 이장훈, "茵蔯이 간성상세포의 섬유화 억제에 미치는 영향", 대한한방내과학회지, 29(1), pp.177~188 (2008), 대한한방내과학회
- 고흥, "茵蔯四苓散 分劃物이 간세포활성, 세포주기 및 Fas-Mediated Apoptosis에 미치는 영향" (2000), 경희대학교 대학원
- 신민효, "임상본초학", pp.172~ (1986), 남산당
- 윤상협, "加減生肝湯이 알코올성 간질환의 간기능 변동에 미치는 영향", 대한한의학회지, 14(2), pp.348~354 (1993)
- 강경태, "실험적 흰쥐의 간경변증에 미치는 영향", 경희한의대논문집, 20(2), pp.133~150 (1997)
- 이지현, "茵蔯分劃物이 인체 간세포의 TGF-β1 induced apoptosis에 미치는 영향", 대한한의학회지, 20(1), pp.53~61 (2000)
- 신상만, "茵蔯이 TGF-β1 유도성 간섬유화에 미치는 영향", 한의학회지, 22(3), pp.141~155 (2001)
- Friedman SL, "he cellular basis of hepatic fibrosis", N Engl J Med, 25, pp.1828~1835 (1993)
- 정규원, "만성간질환의 미세구조-간섬유조직증식과 간유동의 성상세포", 대한간학회지, 8(3), pp.343~353 (2002)
- Yu Q, "Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotestumor invasion and angiogenesis", Gene Dev, 14, pp.163~176 (2000)
- Yi Jong-Hoon, "Effects of Five Fraction of Artemisia Carpillaris THUMB on Fas-mediated Apoptosis in HepG2 Cells", Journal of Oriental Medicine, 4(1), pp.41~45 (1999)
- 조성원, "간섬유화 비침습 진단법의 임상 적용", 대한간학회지, 13(2), pp.129~137 (2007)
- Taubman MB, "Radioimmunoassay for human procollagen", Science, 186(4169), pp.1115~1117 (1974)
- Popper H, "Collagen metabolism in the liver", An annotated and supplemented report of a workshop at the National Institute of Health, 통권 : 23, pp.641~ (1987)
- Rubin E, "Methods in the study of structural changes induced by experimental chronic hepatic injury", Methods Achiev Exp Pathol, 2, pp.224~ (1967)